Intelligence / Healthtech / De Novo Grants / Nanosonics Limited
Approvalsnovel device granted (FDA De Novo)19 Mar 2025
Nanosonics Limited
19 Mar 2025: Novel device granted (FDA De Novo) · CORIS System. Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 19 Mar 2025
- Device
- CORIS System
- Specialty
- General Hospital
- Product Code
- SEW
- Country
- Australia
- Location
- Macquarie Park, Australia
- Submitted
- 2024-05-01
- Reference
- DEN240018
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Nanosonics Limited
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in General Hospital
De Novo Grants
19 AugVitestronovel device granted (FDA De Novo) · Aletta® Autonomous Robotic Phlebotomy Device (ARPD) (Gen1 US)Approvals1 MaySterisnovel device granted (FDA De Novo) · Prolystica Pass Thru Disinfectant WipesApprovals23 DecHai Solutionsnovel device granted (FDA De Novo) · QIKCAP SystemApprovals4 AprPrapela, Inc.novel device granted (FDA De Novo) · Prapela SVS hospital bassinet pad (model P01)Approvals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.